In The News

In The News

September 25, 2018
In a recent interview with Baystate Business, Kevin Hrusovsky, Quanterix Chairman and CEO and founder of Powering Precision Health, explains the fundamentals of Quanterix technology and how it's disrupting the way healthcare is practiced.  Click the file below to hear the interview.
Digital Biotech | September 07, 2018
Kevin Hrusovsky, Quanterix Chairman and CEO and Founder of Powering Precision Health, recently sat down with TetraScience CEO Alok Tayi to talk about the exciting work that Quanterix is doing in the area of clinical biomarkers and the business of diagnostics, as well as healthcare, more broadly,
Practical Neurology | September 05, 2018
A roundtable discussion with Chase Spurlock, PhD, IQuity; Michal Izrael, PhD, Kadimastem Ltd; Kevin Hrusovsky, Quanterix; and J. Michael Ryan, MD, Rodin Therapeutics
Washington Report | September 04, 2018
By: Kevin Hrusovsky
ALZFORUM.ORG | August 24, 2018
A lot can happen in a year.
Specialty Pharmacy Times | August 17, 2018
A new technology allows researchers to use brain biomarker neurofilament light chain (NfL) to uncover insights into the development and progression of neurological diseases, such as multiple sclerosis (MS).  
MD+DI | March 21, 2018
Quanterix teams up with DestiNA to develop assays to detect liver toxicity in patients.